Neural stem cell (NSC) transplantation has provided the basis for the development of potentially powerful new therapeutic cell-based strategies for a broad spectrum of clinical diseases, including stroke, psychiatric illnesses such as fetal alcohol spectrum disorders, and cancer. Here, we discuss pertinent preclinical investigations involving NSCs, including how NSCs can ameliorate these diseases, the current barriers hindering NSC-based treatments, and future directions for NSC research. There are still many translational requirements to overcome before clinical therapeutic applications, such as establishing optimal dosing, route of delivery, and timing regimens and understanding the exact mechanism by which transplanted NSCs lead to enhanced recovery. Such critical lab-to-clinic investigations will be necessary in order to refine NSC-based therapies for debilitating human disorders.

Neural stem cells / Tuazon, J. P.; Castelli, V.; Lee, J. -Y.; Desideri, G.; Stuppia, L.; Cimini, A. M.; Borlongan, C. V.. - (2019), pp. 79-91. - ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. [10.1007/978-3-030-31206-0_4].

Neural stem cells

Desideri G.;
2019

Abstract

Neural stem cell (NSC) transplantation has provided the basis for the development of potentially powerful new therapeutic cell-based strategies for a broad spectrum of clinical diseases, including stroke, psychiatric illnesses such as fetal alcohol spectrum disorders, and cancer. Here, we discuss pertinent preclinical investigations involving NSCs, including how NSCs can ameliorate these diseases, the current barriers hindering NSC-based treatments, and future directions for NSC research. There are still many translational requirements to overcome before clinical therapeutic applications, such as establishing optimal dosing, route of delivery, and timing regimens and understanding the exact mechanism by which transplanted NSCs lead to enhanced recovery. Such critical lab-to-clinic investigations will be necessary in order to refine NSC-based therapies for debilitating human disorders.
2019
Stem cells Therapeutic application
978-3-030-31205-3
cancer; clinical research; fetal alcohol spectrum disorders; graft; neural stem cell; preclinical research; stem cell therapy; stroke
02 Pubblicazione su volume::02a Capitolo o Articolo
Neural stem cells / Tuazon, J. P.; Castelli, V.; Lee, J. -Y.; Desideri, G.; Stuppia, L.; Cimini, A. M.; Borlongan, C. V.. - (2019), pp. 79-91. - ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. [10.1007/978-3-030-31206-0_4].
File allegati a questo prodotto
File Dimensione Formato  
Tuazon_Neural_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 6.7 MB
Formato Adobe PDF
6.7 MB Adobe PDF   Contatta l'autore
Tuazon_frontespizio_Neural_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 87.28 kB
Formato Adobe PDF
87.28 kB Adobe PDF   Contatta l'autore
Tuazon_indice_Neural_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 390.35 kB
Formato Adobe PDF
390.35 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1705244
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 35
social impact